<?xml version="1.0" encoding="UTF-8"?>
<abstract abstract-type="author-highlights" id="abs0005">
 <title>Highlights</title>
 <p>
  <list list-type="simple" id="lis0005">
   <list-item id="lsti0005">
    <label>•</label>
    <p id="par0005">Remdesivir has been found to be potent in vitro inhibitor of RNA viruses including SARS-CoV-2, but its in vivo potency is still under investigation.</p>
   </list-item>
   <list-item id="lsti0010">
    <label>•</label>
    <p id="par0010">This study report the clinical and biological features of five patients hospitalized with COVID-19 and treated with remdesivir for compassionate use.</p>
   </list-item>
   <list-item id="lsti0015">
    <label>•</label>
    <p id="par0015">For two patients, viral loads in nasopharyngeal samples decreased, despite active replication in the lower respiratory tract area.</p>
   </list-item>
   <list-item id="lsti0020">
    <label>•</label>
    <p id="par0020">The treatment had to be interrupted in four of the five patients, because of ALT elevation and/or renal failure.</p>
   </list-item>
  </list>
 </p>
</abstract>
